Cerus Corporation (CERS)
USD 1.21
(-6.2%)
USD 1.21
(-6.2%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 197.74 Million USD | -9.33% |
| 2022 | 218.09 Million USD | -8.17% |
| 2021 | 237.49 Million USD | 7.26% |
| 2020 | 221.41 Million USD | 33.76% |
| 2019 | 165.53 Million USD | 1.27% |
| 2018 | 163.46 Million USD | 66.38% |
| 2017 | 98.24 Million USD | -5.06% |
| 2016 | 103.47 Million USD | -25.81% |
| 2015 | 139.47 Million USD | 70.56% |
| 2014 | 81.77 Million USD | -1.93% |
| 2013 | 83.38 Million USD | 70.45% |
| 2012 | 48.91 Million USD | 7.83% |
| 2011 | 45.36 Million USD | -5.81% |
| 2010 | 48.16 Million USD | 39.65% |
| 2009 | 34.49 Million USD | -27.14% |
| 2008 | 47.33 Million USD | -39.47% |
| 2007 | 78.2 Million USD | -32.47% |
| 2006 | 115.81 Million USD | 97.44% |
| 2005 | 58.66 Million USD | -42.53% |
| 2004 | 102.07 Million USD | -13.83% |
| 2003 | 118.46 Million USD | 62.4% |
| 2002 | 72.94 Million USD | -43.13% |
| 2001 | 128.26 Million USD | 36.21% |
| 2000 | 94.16 Million USD | 125.27% |
| 1999 | 41.8 Million USD | 100.0% |
| 1998 | 20.9 Million USD | -23.44% |
| 1997 | 27.3 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 185.49 Million USD | -1.92% |
| 2024 Q3 | 189.53 Million USD | 2.18% |
| 2024 Q1 | 189.13 Million USD | -4.36% |
| 2023 Q4 | 197.74 Million USD | -3.93% |
| 2023 FY | 197.74 Million USD | -9.33% |
| 2023 Q1 | 209.33 Million USD | -4.01% |
| 2023 Q3 | 205.84 Million USD | 3.51% |
| 2023 Q2 | 198.86 Million USD | -5.0% |
| 2022 Q4 | 218.09 Million USD | 1.25% |
| 2022 FY | 218.09 Million USD | -8.17% |
| 2022 Q2 | 216.45 Million USD | -2.46% |
| 2022 Q1 | 221.9 Million USD | -6.57% |
| 2022 Q3 | 215.4 Million USD | -0.49% |
| 2021 Q2 | 223.22 Million USD | 1.2% |
| 2021 Q3 | 218.94 Million USD | -1.92% |
| 2021 Q4 | 237.49 Million USD | 8.47% |
| 2021 FY | 237.49 Million USD | 7.26% |
| 2021 Q1 | 220.58 Million USD | -0.38% |
| 2020 Q4 | 221.41 Million USD | 3.78% |
| 2020 Q2 | 215.49 Million USD | 0.06% |
| 2020 Q1 | 215.36 Million USD | 30.1% |
| 2020 FY | 221.41 Million USD | 33.76% |
| 2020 Q3 | 213.35 Million USD | -0.99% |
| 2019 Q4 | 165.53 Million USD | 0.67% |
| 2019 FY | 165.53 Million USD | 1.27% |
| 2019 Q1 | 175.92 Million USD | 7.63% |
| 2019 Q3 | 164.43 Million USD | -5.83% |
| 2019 Q2 | 174.62 Million USD | -0.74% |
| 2018 Q3 | 161.65 Million USD | 6.46% |
| 2018 Q2 | 151.84 Million USD | 5.14% |
| 2018 Q1 | 144.42 Million USD | 47.0% |
| 2018 FY | 163.46 Million USD | 66.38% |
| 2018 Q4 | 163.46 Million USD | 1.12% |
| 2017 Q1 | 84.94 Million USD | -17.91% |
| 2017 FY | 98.24 Million USD | -5.06% |
| 2017 Q4 | 98.24 Million USD | 1.19% |
| 2017 Q3 | 97.08 Million USD | 16.29% |
| 2017 Q2 | 83.48 Million USD | -1.71% |
| 2016 Q2 | 120.45 Million USD | -5.85% |
| 2016 FY | 103.47 Million USD | -25.81% |
| 2016 Q3 | 116.12 Million USD | -3.59% |
| 2016 Q4 | 103.47 Million USD | -10.89% |
| 2016 Q1 | 127.93 Million USD | -8.27% |
| 2015 Q1 | 143.22 Million USD | 75.15% |
| 2015 Q4 | 139.47 Million USD | 3.17% |
| 2015 Q3 | 135.18 Million USD | -10.71% |
| 2015 Q2 | 151.4 Million USD | 5.71% |
| 2015 FY | 139.47 Million USD | 70.56% |
| 2014 Q1 | 73.22 Million USD | -12.18% |
| 2014 Q4 | 81.77 Million USD | 3.0% |
| 2014 FY | 81.77 Million USD | -1.93% |
| 2014 Q2 | 76.85 Million USD | 4.95% |
| 2014 Q3 | 79.39 Million USD | 3.31% |
| 2013 Q3 | 79.43 Million USD | -3.77% |
| 2013 Q4 | 83.38 Million USD | 4.96% |
| 2013 FY | 83.38 Million USD | 70.45% |
| 2013 Q1 | 92.2 Million USD | 88.49% |
| 2013 Q2 | 82.54 Million USD | -10.48% |
| 2012 FY | 48.91 Million USD | 7.83% |
| 2012 Q4 | 48.91 Million USD | 0.55% |
| 2012 Q3 | 48.65 Million USD | 5.62% |
| 2012 Q2 | 46.06 Million USD | -11.45% |
| 2012 Q1 | 52.02 Million USD | 14.66% |
| 2011 Q3 | 36.55 Million USD | -6.52% |
| 2011 Q4 | 45.36 Million USD | 24.12% |
| 2011 Q2 | 39.1 Million USD | -14.4% |
| 2011 Q1 | 45.68 Million USD | -5.16% |
| 2011 FY | 45.36 Million USD | -5.81% |
| 2010 FY | 48.16 Million USD | 39.65% |
| 2010 Q3 | 32.16 Million USD | 7.59% |
| 2010 Q4 | 48.16 Million USD | 49.77% |
| 2010 Q2 | 29.89 Million USD | -8.02% |
| 2010 Q1 | 32.49 Million USD | -5.78% |
| 2009 FY | 34.49 Million USD | -27.14% |
| 2009 Q1 | 39.16 Million USD | -17.27% |
| 2009 Q3 | 43.02 Million USD | 24.5% |
| 2009 Q4 | 34.49 Million USD | -19.84% |
| 2009 Q2 | 34.56 Million USD | -11.75% |
| 2008 Q3 | 52.39 Million USD | -18.4% |
| 2008 FY | 47.33 Million USD | -39.47% |
| 2008 Q2 | 64.21 Million USD | -8.3% |
| 2008 Q4 | 47.33 Million USD | -9.65% |
| 2008 Q1 | 70.02 Million USD | -10.47% |
| 2007 FY | 78.2 Million USD | -32.47% |
| 2007 Q3 | 85.03 Million USD | -7.39% |
| 2007 Q4 | 78.2 Million USD | -8.02% |
| 2007 Q2 | 91.81 Million USD | -13.52% |
| 2007 Q1 | 106.16 Million USD | -8.33% |
| 2006 Q1 | 99.95 Million USD | 70.39% |
| 2006 Q2 | 91.36 Million USD | -8.6% |
| 2006 Q3 | 89.01 Million USD | -2.57% |
| 2006 Q4 | 115.81 Million USD | 30.12% |
| 2006 FY | 115.81 Million USD | 97.44% |
| 2005 Q4 | 58.66 Million USD | 3.27% |
| 2005 Q3 | 56.8 Million USD | -3.37% |
| 2005 FY | 58.66 Million USD | -42.53% |
| 2005 Q1 | 62.57 Million USD | -38.7% |
| 2005 Q2 | 58.78 Million USD | -6.06% |
| 2004 Q3 | 96.3 Million USD | -5.78% |
| 2004 Q4 | 102.07 Million USD | 6.0% |
| 2004 Q2 | 102.21 Million USD | -6.04% |
| 2004 Q1 | 108.78 Million USD | -8.17% |
| 2004 FY | 102.07 Million USD | -13.83% |
| 2003 FY | 118.46 Million USD | 62.4% |
| 2003 Q3 | 131.36 Million USD | -8.98% |
| 2003 Q4 | 118.46 Million USD | -9.82% |
| 2003 Q2 | 144.32 Million USD | 37.21% |
| 2003 Q1 | 105.18 Million USD | 44.19% |
| 2002 Q3 | 90.29 Million USD | -16.04% |
| 2002 Q4 | 72.94 Million USD | -19.21% |
| 2002 Q1 | 116.07 Million USD | -9.5% |
| 2002 FY | 72.94 Million USD | -43.13% |
| 2002 Q2 | 107.54 Million USD | -7.35% |
| 2001 Q2 | 151.54 Million USD | 79.38% |
| 2001 Q4 | 128.26 Million USD | -9.55% |
| 2001 FY | 128.26 Million USD | 36.21% |
| 2001 Q3 | 141.79 Million USD | -6.43% |
| 2001 Q1 | 84.48 Million USD | -10.28% |
| 2000 Q4 | 94.16 Million USD | -10.07% |
| 2000 FY | 94.16 Million USD | 125.27% |
| 2000 Q1 | 58.91 Million USD | 40.95% |
| 2000 Q2 | 51.9 Million USD | -11.91% |
| 2000 Q3 | 104.7 Million USD | 101.73% |
| 1999 Q2 | 59.4 Million USD | 123.31% |
| 1999 Q1 | 26.6 Million USD | 27.27% |
| 1999 Q3 | 49.6 Million USD | -16.5% |
| 1999 Q4 | 41.8 Million USD | -15.73% |
| 1999 FY | 41.8 Million USD | 100.0% |
| 1998 Q4 | 20.9 Million USD | -13.28% |
| 1998 FY | 20.9 Million USD | -23.44% |
| 1998 Q1 | 24.4 Million USD | -10.62% |
| 1998 Q3 | 24.1 Million USD | 24.23% |
| 1998 Q2 | 19.4 Million USD | -20.49% |
| 1997 Q4 | 27.3 Million USD | 7.06% |
| 1997 Q1 | 31.9 Million USD | 0.0% |
| 1997 FY | 27.3 Million USD | 0.0% |
| 1997 Q2 | 27.9 Million USD | -12.54% |
| 1997 Q3 | 25.5 Million USD | -8.6% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -530.453% |
| BrainsWay Ltd. | 62.97 Million USD | -214.025% |
| Envoy Medical, Inc. | 7.64 Million USD | -2488.325% |
| electroCore, Inc. | 16.38 Million USD | -1106.737% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -2470.827% |
| IceCure Medical Ltd | 16.41 Million USD | -1105.046% |
| Inogen, Inc. | 326.19 Million USD | 39.377% |
| OrthoPediatrics Corp. | 449.58 Million USD | 56.016% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -625.149% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -1092.761% |
| MaxCyte, Inc. | 268.27 Million USD | 26.289% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -2342.143% |
| Nexalin Technology, Inc. | 3.63 Million USD | -5344.729% |
| Orthofix Medical Inc. | 925.31 Million USD | 78.629% |
| PAVmed Inc | 33.11 Million USD | -497.083% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | -37.85% |
| RxSight, Inc. | 182.55 Million USD | -8.325% |
| Sight Sciences, Inc. | 166.65 Million USD | -18.66% |
| SI-BONE, Inc. | 230.42 Million USD | 14.181% |
| TELA Bio, Inc. | 78.04 Million USD | -153.367% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 21.5% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -1742.945% |
| Acutus Medical, Inc. | 53.96 Million USD | -266.471% |
| Talis Biomedical Corporation | 98.34 Million USD | -101.086% |
| Spectral AI, Inc. | 10.69 Million USD | -1749.495% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 9.559% |
| CVRx, Inc. | 115.22 Million USD | -71.613% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -237.103% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -6247.735% |
| Bioventus Inc. | 810.91 Million USD | 75.614% |
| Venus Concept Inc. | 93.65 Million USD | -111.147% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -668.7% |
| LivaNova PLC | 2.42 Billion USD | 91.861% |
| 908 Devices Inc. | 202.98 Million USD | 2.578% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 75.441% |
| Nemaura Medical Inc. | 14.56 Million USD | -1257.858% |
| NeuroPace, Inc. | 107.65 Million USD | -83.694% |
| LENSAR, Inc. | 69.58 Million USD | -184.182% |
| Apyx Medical Corporation | 79.24 Million USD | -149.556% |
| Cutera, Inc. | 346.29 Million USD | 42.895% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -370.649% |
| BioSig Technologies, Inc. | 1.79 Million USD | -10898.22% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 26.931% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -363.533% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 94.771% |
| Axonics, Inc. | 719.92 Million USD | 72.532% |
| Outset Medical, Inc. | 313.8 Million USD | 36.983% |
| IRIDEX Corporation | 34.43 Million USD | -474.248% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 51.139% |
| IRadimed Corporation | 92.15 Million USD | -114.579% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -3663.761% |
| INVO Bioscience, Inc. | 20.88 Million USD | -846.716% |
| Telesis Bio, Inc. | 70.41 Million USD | -180.848% |
| Viemed Healthcare, Inc. | 154.1 Million USD | -28.322% |
| Varex Imaging Corporation | 1.24 Billion USD | 84.175% |
| Quipt Home Medical Corp. | 247.4 Million USD | 20.072% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -2024.039% |
| Pulmonx Corporation | 178.95 Million USD | -10.504% |
| Dynatronics Corporation | 25.94 Million USD | -662.312% |
| Modular Medical, Inc. | 13.8 Million USD | -1332.23% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -1743.46% |
| Semler Scientific, Inc. | 78.06 Million USD | -153.312% |
| InMode Ltd. | 863.28 Million USD | 77.094% |
| Bruker Corporation | 4.24 Billion USD | 95.347% |
| Cytosorbents Corporation | 53.26 Million USD | -271.284% |
| DexCom, Inc. | 6.26 Billion USD | 96.843% |
| Align Technology, Inc. | 6.08 Billion USD | 96.75% |
| Viveve Medical, Inc. | 25.91 Million USD | -663.123% |
| ZimVie Inc. | 1.2 Billion USD | 83.594% |
| Movano Inc. | 9.42 Million USD | -1999.013% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 60.265% |
| Nexalin Technology, Inc. | 3.63 Million USD | -5344.729% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -237.103% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 79.242% |
| Profound Medical Corp. | 43.68 Million USD | -352.654% |
| Insulet Corporation | 2.58 Billion USD | 92.36% |
| enVVeno Medical Corporation | 48.63 Million USD | -306.596% |
| Surmodics, Inc. | 185.73 Million USD | -6.469% |
| iCAD, Inc. | 41.41 Million USD | -377.445% |
| Nuwellis, Inc. | 9.77 Million USD | -1924.033% |
| Biotricity, Inc. | 5.94 Million USD | -3227.62% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 54.346% |
| Aethlon Medical, Inc. | 8.24 Million USD | -2298.113% |
| InspireMD, Inc. | 47.64 Million USD | -315.062% |
| PAVmed Inc. | 33.11 Million USD | -497.083% |
| BIOLASE, Inc. | 35.1 Million USD | -463.369% |
| Beyond Air, Inc. | 56.96 Million USD | -247.164% |
| FONAR Corporation | 214.24 Million USD | 7.7% |
| AxoGen, Inc. | 196.82 Million USD | -0.468% |
| Vivani Medical, Inc. | 45.79 Million USD | -331.792% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 29.737% |
| Inari Medical, Inc. | 674.23 Million USD | 70.671% |
| UFP Technologies, Inc. | 404.13 Million USD | 51.069% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -745.129% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -1980.876% |
| Tenon Medical, Inc. | 6.34 Million USD | -3016.596% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -2002.137% |
| Co-Diagnostics, Inc. | 103.64 Million USD | -90.789% |
| AdaptHealth Corp. | 4.61 Billion USD | 95.72% |
| Sintx Technologies, Inc. | 15.36 Million USD | -1187.003% |
| NanoVibronix, Inc. | 6.67 Million USD | -2862.961% |
| Quanterix Corporation | 425.01 Million USD | 53.472% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -2024.039% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -268.061% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 88.674% |
| TransMedics Group, Inc. | 706.04 Million USD | 71.992% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -212.932% |
| NeuroMetrix, Inc. | 21.42 Million USD | -823.002% |
| Hyperfine, Inc. | 94.19 Million USD | -109.926% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 26.389% |
| Biomerica, Inc. | 9.25 Million USD | -2036.892% |
| Bone Biologics Corporation | 3.73 Million USD | -5190.544% |
| AVITA Medical, Inc. | 144.33 Million USD | -37.002% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -3961.759% |
| Silk Road Medical, Inc | 265.3 Million USD | 25.465% |